Access to anti-retroviral drugs, female in Niger
Niger: Access to anti-retroviral drugs, female was 79.0% in 2024. ◆ Volatile
Access to anti-retroviral drugs, female in Niger, 2000–2024
Source: UNAIDS estimates. Measured in %.
Analysis
In 2024, access to anti-retroviral drugs, female in Niger stood at 79.0%.
The figure is down 4.8% on the previous year and up 75.6% over ten years.
Over the whole period, access to anti-retroviral drugs, female in Niger peaked at 85.0% in 2020 and was at its lowest, 0.0%, in 2000.
That places Niger 59th out of 141 countries with data for 2024, putting it in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Access to anti-retroviral drugs, female in Niger, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.0% | — |
| 2003 | 0.0% | — |
| 2004 | 0.0% | — |
| 2005 | 2.0% | — |
| 2006 | 6.0% | +200.0% |
| 2007 | 8.0% | +33.3% |
| 2008 | 10.0% | +25.0% |
| 2009 | 24.0% | +140.0% |
| 2010 | 28.0% | +16.7% |
| 2011 | 36.0% | +28.6% |
| 2012 | 42.0% | +16.7% |
| 2013 | 50.0% | +19.0% |
| 2014 | 45.0% | -10.0% |
| 2015 | 52.0% | +15.6% |
| 2016 | 60.0% | +15.4% |
| 2017 | 72.0% | +20.0% |
| 2018 | 79.0% | +9.7% |
| 2019 | 81.0% | +2.5% |
| 2020 | 85.0% | +4.9% |
| 2021 | 85.0% | +0.0% |
| 2022 | 84.0% | -1.2% |
| 2023 | 83.0% | -1.2% |
| 2024 | 79.0% | -4.8% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 5.0% | 0.0% | 24.0% | 10 |
| 2010s | 54.5% | 28.0% | 81.0% | 10 |
| 2020s | 83.2% | 79.0% | 85.0% | 5 |
Countries ranked near Niger
More gender data for Niger
- Child population (UN estimates and projections) 14,378 (2030)
- Child population (UN estimates and projections) (0-14), annual growth 2.03 % change on previous year (2030)
- Population 18,140 (2030)
- Working-age population (UN estimates and projections) 18,140 (2030)
- Population (UN estimates and projections), annual growth rate 3.76 % change on previous year (2030)
- Age population, age 00, female, interpolated 528,190 (2025)
- Age population, age 00, male, interpolated 546,108 (2025)
- Age population, age 01, female, interpolated 503,963 (2025)
- Age population, age 01, male, interpolated 519,307 (2025)
- Age population, age 02, female, interpolated 480,074 (2025)
Frequently asked questions
- What is access to anti-retroviral drugs, female in Niger?
- Access to anti-retroviral drugs, female in Niger was 79.0% in 2024, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, female recorded in Niger?
- The highest recorded value was 85.0% in 2020.
- What is the lowest access to anti-retroviral drugs, female recorded in Niger?
- The lowest recorded value was 0.0% in 2000.
- How does Niger rank for access to anti-retroviral drugs, female?
- Niger ranks 59th out of 141 countries with data for 2024.
- Is access to anti-retroviral drugs, female rising or falling in Niger?
- Over the last ten years it is up 75.6%. The long-run trend across the full record is volatile.
- Where does this Niger data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, female (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.